What this means
This is a plan to adjust an existing care program for older people with myeloma, a blood cancer. The goal is to spot loss of daily ability sooner and help prevent it. The study is still recruiting, so it cannot yet show whether the program works.
Plain-English summary written by an AI model from the registry listing.
- Status
- Recruiting
- Who can join
- Ages 70 and over
- Where
- 1 site
The science
- Registered title
- ICOPE Program Feasibility in the Management of Myeloma Patients
- Trial ID
- NCT06247189 ↗
- Phase
- Not applicable
- Study type
- interventional
- Conditions
- Frailty, Multiple Myeloma
- What is tested
- ICOPE Monitoring
- Sponsor
- University Hospital, Toulouse
- Ages
- 70 Years to no maximum
- Dates
- First posted Feb 7, 2024 · updated Dec 22, 2025
Registry summary
This project proposes to adapt monthly the existing ICOPE (Integrated Care for Older People) MONITOR program for elderly myeloma patients. This adaptation aims to detect earlier functional decline and prevent loss of autonomy.
Sites (1)
- CHU de Toulouse, Toulouse, France